Athenex 宣佈將在 2020 年聖安東尼奧乳癌研討會 (SABCS) 介紹口服紫杉醇及 Encequidar 的數據

NEXT STORY
Subcutaneous Drug Delivery Devices Market Is Expected to Generate Revenue Worth US$ 71 billion by 2030, Globally
PREV STORY
Update:  Global WholeHealth Partners, Corp (GWHP: OTC) Describes the Pros and Cons of the Common Types of COVID-19 Test Kits Available
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma

- Durable Stable Disease Observed for Patients with Non-enhancing Low Grade Glioma and Chondrosarcoma ...

author_avatar
NASDAQ Market News

Pacific Mercantile Bank Joins the Mission Hospital Corporate Partners Program

COSTA MESA, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- Pacific Mercantile Bank (“the Bank”), ...

author_avatar
NASDAQ Market News

US Department of Defense Reports Travelan Protects Against Shigella in Primates

Key Highlights: Travelan® pre-clinical shigellosis challenge studies in non-human primates (NHP) successfully completedTravelan® prevented ...

author_avatar
NASDAQ Market News